加科思药业集团有限公司（股票名称：加科思-B，股票代码：01167）于2026年7月21日发布公告，披露当日进行了股份购回。
公告显示，公司当日回购98,400股普通股，占回购前已发行股本（不包括库藏股）约0.01258%。每股购回价格介乎港币5.06元至5.08元，合计涉资港币49.86万元。回购完成后，公司已发行股份（不包括库藏股）数目为782,374,980股，库藏股数目为9,380,100股。
购回授权于2026年6月5日获通过，公司可根据该授权购回股份总数为78,372,528股，已累计购回1,350,300股。公司确认本次股份购回符合香港联交所证券上市规则及相关法例的要求。
本次公告由董事王晓洁签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.